An understanding of disease processes drives innovation in medicine
"A thinker sees his own actions as experiments
and questions, as attempts to find out something.
Success and failure are for him answers above all."
"There is one thing even more vital to science than intelligent
methods; and that is the sincere desire to find out the truth,
whatever it may be."
- Charles Pierce
"Every great advance in science has issued
from a new audacity of imagination"
- John Dewey
"Somewhere, something incredible is waiting to be known"
- Carl Sagan
"There is nothing which can better deserve your patronage
than the promotion of science and literature. Knowledge is in every country the surest basis of public happiness."
- George Washington
"Learn from yesterday, live for today, hope for tomorrow
The important thing is to not stop questioning."
- Albert Einstein
Welcome to the website of the CellCOM Research Group. Our group is a translational and clinical research group within the Institute of Biomedical Research of A Coruña (INIBIC), part of the University Hospital Complex A Coruña, which provides a strong clinical basis for laboratory-based research. Our approaches combine in vitro, ex vivo and in vivo models to conduct pre-clinical studies in age-related diseases and cancer. Our group is a multidisciplinary team that includes basic scientists (predoctoral, postdoctoral fellows and technicians) and clinical researchers such as pathologists, dermatologists, radiologists and surgeons.
Our aims are to understand the physiopathology of connexin-linked diseases (cancer, inflammation, tissue degeneration), to design molecules and new drugs that modulate the activity of specific targets and to identify novel markers of disease prevention, diagnosis and disease management.
We are focused on understanding the role of connexins and pannexins in osteoarthritis, skin wound healing in oncological patients, metastasis and resistance to targeted cancer therapies and immunotherapies. Our final goal is to identify effective therapeutic targets to design specific and successful therapeutic approaches to treat these disorders.
Follow us on Twitter to stay updated on news
“Francisco Guitián Ojea” Award I RAGC
July 2020 Galician Royal Academy of Sciences (RAGC) Awards Thanks to RAGC for the «Francisco Guitián Ojea» Award to our research in oncology. In this project we have found two molecules with…
EMBO Short-Term Fellowship
April 2020 EMBO Short-Term Fellowship Thanks to EMBO for the EMBO Short-Term Fellowship to Marina Rodriguez-Candela Mateos to visit Winfried Wels lab at Georg-Speyer-Haus in the Institute for Tumor Biology…
María Mayán at the Governing bodies of SEBBM
July 2020 New Boards of Directors at SEBBM The Governing Boards lead by the new President, Isabel Varela Nieto, at SEBBM include María Mayán as Ordinary Member of the team.…
Woman in Science: presentation of ASEICA Mujer in Bilbao
Oct 2019 ASEICA Mujer – Spanish Association for Cancer Research (ASEICA) We are glad to support and participate in the presentation and first event of ASEICA-Mujer to promote and enhance the…
Women in Science I AECC-Coruña
January 2020 AECC-Coruña «Con nombre de mujer: Ciencia a pie de calle» The event was organized by AECC-Coruña and ASEICA-Mujer in collaboration with SEBBM and Corbi Foundation and Colegio Oficial de…
Connexin and pannexin channels in inflammation, tissue regeneration and cancer
Oct 2019 Science Xpression 2019 Seventh edition of Science Xpression workshop We have enjoyed the session of conferences with internacional experts in the study of the role connexins and pannexins…